📦 NDC / package directory — not a drug information page
Daratumumab And Hyaluronidase-Fihj (Human Recombinant) NDCs, Package Codes, Strengths & Labelers
This page lists NDC package records for Daratumumab And Hyaluronidase-Fihj (Human Recombinant) products — strengths, dosage forms, package sizes, labelers, 11-digit billing NDCs, pricing data when available, and links to each individual NDC page. It’s an NDC/package & billing directory, not a clinical drug page.
Key stats
1
Package NDCs
2
Products
2
Active listings
0
Discontinued
1
Labelers
1
Strengths
1
Dosage forms
0
With NADAC pricing
By strength, form & labeler
NDC products by strength
By dosage form
Top labelers
Browse records — 2 products
| Drug / product | Billing NDC | NADAC / unit | Status | |
|---|---|---|---|---|
| Darzalex Faspro daratumumab and hyaluronidase-fihj (human recombinant) 1800 mg/15mL; 30000 U/15mL INJECTION | 57894-0503-01 | — | On market | View → |
| Darzalex Faspro daratumumab and hyaluronidase-fihj (human recombinant) 1800 mg/15mL; 30000 U/15mL INJECTION | 57894-0503-01 | — | On market | View → |
Where does this data come from?
NDC package records, strengths, forms and labelers come from the openFDA NDC Directory; pricing is CMS NADAC. Grouped by active-ingredient name. This is package/billing reference data, not clinical drug information.